Endo International plc News Releases http://investor.endo.com/ Endo International plc News Releases en Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health Month http://investor.endo.com/news-releases/news-release-details/nationally-recognized-urologist-and-author-aaron-spitz-md-teams DUBLIN and MALVERN, Pa. , June 6, 2019 /PRNewswire/ -- Ask About the Curve raises awareness of Peyronie's disease, a men's health condition that may affect about 1 in 10 men and leads to a pronounced curvature in the penis and potential pain during arousal. Endo Pharmaceuticals and Dr. Thu, 06 Jun 2019 07:30:00 -0400 Endo International plc News Releases 15286 Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019 http://investor.endo.com/news-releases/news-release-details/phase-3-data-collagenase-clostridium-histolyticum Clinical Investigator Dr. Lawrence Bass is a Featured Hot Topics Speaker DUBLIN , May 17, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that clinical data from a Phase 3 investigational study of collagenase clostridium histolyticum (CCH) for the treatment of cellulite Fri, 17 May 2019 07:00:00 -0400 Endo International plc News Releases 15261 Endo to Participate at RBC Healthcare Conference http://investor.endo.com/news-releases/news-release-details/endo-participate-rbc-healthcare-conference DUBLIN , May 15, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the RBC Annual Healthcare Conference in New York City on Tuesday, May 21, 2019 at 10:00 a.m. ET . Wed, 15 May 2019 17:00:00 -0400 Endo International plc News Releases 15251 Endo Reports First-Quarter 2019 Financial Results http://investor.endo.com/news-releases/news-release-details/endo-reports-first-quarter-2019-financial-results DUBLIN , May 9, 2019 /PRNewswire/ -- First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile Injectables revenues increased 25 percent to $270 million compared to first-quarter 2018 revenues of $216 million Thu, 09 May 2019 06:30:00 -0400 Endo International plc News Releases 15226 Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product http://investor.endo.com/news-releases/news-release-details/par-pharmaceutical-inc-issues-voluntary-nationwide-recall-one DUBLIN , May 1, 2019 /PRNewswire/ -- Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level. Wed, 01 May 2019 17:35:00 -0400 Endo International plc News Releases 15216 Endo to Announce First-Quarter 2019 Financial Results http://investor.endo.com/news-releases/news-release-details/endo-announce-first-quarter-2019-financial-results DUBLIN , April 10, 2019 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2019 financial results on May 9, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a.m. ET before the U.S. financial markets open. Wed, 10 Apr 2019 17:00:00 -0400 Endo International plc News Releases 15161 Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States http://investor.endo.com/news-releases/news-release-details/endo-begins-shipment-authorized-generic-version-proventilr DUBLIN , April 5, 2019 /PRNewswire/ --   Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's PROVENTIL ® (albuterol sulfate) HFA Inhalation Aerosol, 120mcg. Fri, 05 Apr 2019 07:30:00 -0400 Endo International plc News Releases 15156 Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes http://investor.endo.com/news-releases/news-release-details/endo-international-plc-announces-early-tender-results-its DUBLIN , March 27, 2019 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) (the "Company" or " Endo ")  today announced the early tender results of the previously announced cash tender offers (the "Tender Offers") made by Endo Finance LLC ("Endo Finance"), a wholly-owned subsidiary of Endo Wed, 27 Mar 2019 21:11:00 -0400 Endo International plc News Releases 15051 Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery http://investor.endo.com/news-releases/news-release-details/endo-announces-publication-collagenase-clostridium-histolyticum Leading Peer-Reviewed Dermatology Journal Features Phase 2 Data DUBLIN , March 19, 2019 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") for the treatment of cellulite in Dermatologic Tue, 19 Mar 2019 07:30:00 -0400 Endo International plc News Releases 15041 Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations http://investor.endo.com/news-releases/news-release-details/endo-international-plc-announces-upsizing-its-cash-tender-offers DUBLIN , March 14, 2019 /PRNewswire/ --   Endo International plc (NASDAQ: ENDP) today announced an upsizing of its previously announced cash tender offers (the "Tender Offers") and consent solicitations by Endo Finance LLC ("Endo Finance"), a wholly-owned subsidiary of Endo International plc . Thu, 14 Mar 2019 20:06:00 -0400 Endo International plc News Releases 15031